Several versions of Eltrombopag/Eltrombopag

Eltrombopag/The original manufacturer of Eltrombopag is Novartis. There are also some different brands and trade names, such as Promacta (US version) and Revolade (European/Indian version). These brands and trade names may be manufactured by different pharmaceutical companies and sold in different countries and regions. Regarding generic manufacturers, generic drugs of eltrombopag are produced in many regionsCommon generic drug manufacturers include Yaopin International in Bangladesh, Lucius Pharmaceuticals in Laos, and NATCO Pharmaceuticals in IndiaNATCO Pharmaceutical Factory, etc.

The main indication for eltrombopag is immune thrombocytopenia (ITP), an autoimmune disease that causes the immune system to attack and destroy platelets, reducing their number. Eltrombopag helps restore normal platelet levels by ** platelet production in the bone marrow, thereby reducing the risk of bleeding and other symptoms associated with thrombocytopenia. In addition to ITP, eltrombopag can also be used to treat some other thrombocytopenias, such as those caused by chronic liver disease and those caused after chemotherapy.

Eltrombopag is usually taken as an oral tablet. Its dosage and frequency of use will vary based on the patient's specific condition and doctor's recommendations. Before starting eltrombopag, your doctor may perform a series of tests, including platelet counts and other related indicators, to evaluate the patient's condition and determine the most appropriate treatment plan. Eltrombopag may cause some side effects, including dizziness, nausea, vomiting, abdominal pain, and itchy skin. During the use of the drug, regular blood tests are also necessary to monitor changes in platelet counts and other related indicators, and to adjust the dose or discontinue the drug as needed.